|
|
Article: Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors.
- Article from:
- Biotech Week
- Article date:
- August 12, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Marinus Pharmaceuticals, Inc. a developer of drugs to treat serious neurological and psychiatric disorders, announced the appointment of George F. Horner III of Sofinnova Ventures and Harry T. Rein of Foundation Medical Partners to its Board of Directors (see also Pharmaceuticals).
"We are thrilled to expand our board of directors with George and Harry, both of whom have tremendous track records for advancing drug pipelines, leading pharmaceutical and life sciences companies and in delivering value to stakeholders," said John Krayacich, CEO , president and director of Marinus Pharmaceuticals. "Their expertise will be extremely valuable as we progress our lead ...
Related newspaper, magazine, and journal articles:
|
|
Article: Marinus Pharmaceuticals, Inc. Announces Positive ...
PR Newswire;
March 3, 2009 ;
700+ words
... ... BRANFORD, Conn., March 3 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. today announced that it met its primary ... commented John Krayacich, president and CEO of Marinus Pharmaceuticals, Inc. "We look forward to continuing the ...
|
|